Publications by authors named "Jaro Wex"

Claim this Profile
E
Exploring the feasibility of using the ICER Evidence Rating Matrix for Comparative Clinical Effectiveness in assessing treatment benefit and certainty in the clinical evidence on orphan therapies for paediatric indications.
Jaro Wex, Monika Szkultecka-Debek, Mariola Drozd, Sarah King, Natasa Zibelnik

Orphanet J Rare Dis· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative effectiveness of mepolizumab and omalizumab in severe asthma: An indirect treatment comparison.
Sarah M Cockle, Gillian Stynes, Necdet B Gunsoy, Daniel Parks, Rafael Alfonso-Cristancho, Jaro Wex

Respir Med· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once-daily fluticasone furoate/vilanterol versus twice daily combination therapies in asthma-mixed treatment comparisons of clinical efficacy.
Henrik Svedsater, Gillian Stynes, Jaro Wex, Lucy Frith, David Leather

Asthma Res Pract· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once-daily fluticasone furoate/vilanterol 100/25 mcg versus twice daily combination therapies in COPD - mixed treatment comparisons of clinical efficacy.
Gillian Stynes, Henrik Svedsater, Jaro Wex, Sally Lettis, David Leather

Respir Res· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic evaluation of highly purified human menopausal gonadotropin versus recombinant human follicle-stimulating hormone in fresh and frozen in vitro fertilization/intracytoplasmic sperm-injection cycles in Sweden.
Jaro Wex, Ahmed M Abou-Setta

Clinicoecon Outcomes Res· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leuprolide acetate 1-, 3- and 6-monthly depot formulations in androgen deprivation therapy for prostate cancer in nine European countries: evidence review and economic evaluation.
Jaro Wex, Manpreet Sidhu, Isaac Odeyemi, Ahmed M Abou-Setta, Peny Retsa

Clinicoecon Outcomes Res· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atosiban versus betamimetics in the treatment of preterm labour in Italy: clinical and economic importance of side-effects.
Jaro Wex, Ahmed M Abou-Setta, Graziano Clerici, Gian Carlo Di Renzo

Eur J Obstet Gynecol Reprod Biol· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atosiban versus betamimetics in the treatment of preterm labour in Germany: an economic evaluation.
Jaro Wex, Mark Connolly, Werner Rath

BMC Pregnancy Childbirth· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis